Klinic offers four FDA-approved medications for weight management: Zepbound (injectable tirzepatide, once weekly), Wegovy (injectable semaglutide, once weekly), Oral Wegovy (semaglutide tablet, once daily), and Foundayo (orforglipron tablet, once daily)
Over 36 months, the cumulative incidence of NAION was 6.7% in the semaglutide cohort (95% CI, 3.6%-9.7%) compared with 0.8% in the non-GLP-1 RA cohort (95% CI, 0%-1.8%)
A growing number of publications demonstrate that hyperuricaemia has been proved to be a risk for multiple diseases including gout, chronic kidney disease (CKD), cardiovascular diseases
Followed the protocol
Its also important to note that the supplement promotes a more even, radiant-looking complexion, rather than drastic or overnight whitening